Vanguard Personalized Indexing Management, LLC

Position in CYTK — Cytokinetics Inc

CIK 1767306 OAKLAND, CA

Position in CYTK

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$2,243,904

+$672,940 QoQ

Shares Held

26,340

+10.5% QoQ

Ownership

0.019%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#213

of 477 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 55% Shared 0% None 45%

Healthcare · as of Jun 30, 2026

Vanguard Personalized Indexing Management, LLC holds $97,369,187 across 138 Biotechnology names. CYTK ranks #10 (2.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	43,151	$21,434,396
2	REGN	Regeneron Pharmaceuticals, Inc.	11,712	$7,302,900
3	INCY	Incyte Corp	34,556	$3,917,268
4	ARGX	Argenx SE	4,103	$3,806,640
5	ALNY	Alnylam Pharmaceuticals, Inc.	11,436	$3,442,579
6	RVMD	Revolution Medicines, Inc.	17,697	$3,314,294
7	MRNA	Moderna, Inc.	43,679	$3,058,840
8	HALO	Halozyme Therapeutics, Inc.	30,414	$2,380,503

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,243,904	26,340	+10.5%	Shares	Sole	2026-08-11
2026-03-31	$1,570,964	23,835	+15.0%	Shares	Sole	2026-05-14
2025-12-31	$1,316,866	20,725	+14.6%	Shares	Sole	2026-02-13
2025-09-30	$993,896	18,084	+33.1%	Shares	Sole	2025-10-31
2025-06-30	$449,046	13,591	+12.5%	Shares	Sole	2025-07-25
2025-03-31	$485,575	12,082	+72.9%	Shares	Sole	2025-05-14
2024-12-31	$328,621	6,986	+4.6%	Shares	Sole	2025-02-10
2024-09-30	$352,756	6,681	-16.9%	Shares	Sole	2024-11-12
2024-06-30	$435,823	8,044	-7.3%	Shares	Sole	2024-08-12
2024-03-31	$608,695	8,682	+58.2%	Shares	Sole	2024-05-09
2023-12-31	$458,276	5,489	—	Shares	Sole	2024-02-08
No filing history on record for this holder in this stock.